The RFC1 G80A polymorphism is closely associated with higher rates of methotrexate-induced toxicity in pediatric acute lymphoblastic leukemia (ALL), according to a study published in the World Journal ...

HealthDay News — In guidelines issued by the American Society of Hematology and published online February 11 in Blood Advances, recommendations are presented for frontline management of acute ...

Hematologist-oncologists are doctors who specialize in treating blood cancers such as acute lymphoblastic leukemia (ALL). ALL is a rare, rapidly progressing cancer of the blood and bone marrow. The ...

Supportive care aims to ensure that patients with acute lymphoblastic leukemia (ALL) derive the most benefit from ALL therapy despite the intensive treatments they undergo. Supportive care should be ...

Researchers determined AYAs with ALL trying to schedule oncology appointments face logistical burdens when accessing initial oncology care.

Elias Jabbour, MD, is a board-certified hematologist-oncologist and internationally recognized leukemia specialist. He is a Professor of Medicine and Chief of the Acute Lymphoblastic Leukemia (ALL) ...

Lacey High School senior Alex Pastore had a cough he just couldn't shake. It turned out to be T-cell acute lymphoblastic leukemia.

Acute Lymphocytic Leukemia (ALL) is a serious type of cancer that affects the blood and bone marrow. It moves very quickly, meaning it needs fast and strong treatment. In ALL, the body starts making ...